Poster presented at ESMO 2018 Congress: 430P - Phase I study: Safety and tolerability of Varlitinib (VAR) in combination with Oxaliplatin and Capecitabine (COX) or Oxaliplatin and 5-FU (FOL) in advanced solid
European Society for Medical Oncology
Poster presented at ESMO 2018 Congress: 1043TiP - A phase IIA dose optimization study of ASLAN003 in acute myeloid leukemia (AML) - ASLAN Pharmaceuticals
PosterSessionOnline
ACT Genomics SG - ACT Genomics is proud to be selected for abstract poster presentation in ESMO 2018 Congress which starting from today till 23 October at Munich, Germany. In one of
ESMO | ESMO
Gustave Roussy at the ESMO 2018 Congress | Gustave Roussy
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
Information for Presenters | ESMO TAT 2023
swallowsgroup on X: "So proud to have our poster on display today at ESMO Conference Head & Neck cancer 1110P come and take a look interesting stats #ESMO18 https://t.co/hUijMmaaed" / X
Abstracts | ESMO Congress 2022
European Society for Medical Oncology
INCA Best Poster ESMO Munich 2018 | NETwork!
ESMO 2018 Congress | ID SOLUTIONS
ESMO 2018 Congress: ICHOM - All.Can - All.Can
ESMO 2018 - Day 1 | European Society for Medical Oncology | Flickr